Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke (Q28218187)

Advances in stroke research: basic science, treatment, and clinical trials outcomes. Highlights of the 29th International Stroke Conference, February 5-7, 2004, San Diego, CA

Europe PubMed Central

title

Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke (English)

0 references

author name string

Jesse Weinberger

series ordinal

1

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

Drugs

0 references

volume

65

0 references

issue

4

0 references

page(s)

461-71

0 references

cites work

1 reference

12 December 2020

Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Clopidogrel-associated angioedema

1 reference

12 December 2020

Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination

1 reference

12 December 2020

Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin

1 reference

12 December 2020

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

1 reference

12 December 2020

Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration

1 reference

12 December 2020

Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association

1 reference

12 December 2020

Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial

1 reference

12 December 2020

Management of cerebral embolism of cardiac origin

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with clopidogrel

1 reference

12 December 2020

Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial

1 reference

12 December 2020

Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin

1 reference

12 December 2020

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

1 reference

12 December 2020

History of aspirin and its mechanism of action.

1 reference

12 December 2020

Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested

1 reference

12 December 2020

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

12 December 2020

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

12 December 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

Dual antiplatelet therapy for prevention of recurrent ischemic events

1 reference

12 December 2020

Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits

1 reference

12 December 2020

Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis

1 reference

12 December 2020

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

12 December 2020

The action of ticlopidine on human platelets. Studies on aggregation, secretion, calcium mobilization and membrane glycoproteins

1 reference

12 December 2020

Lifetime cost of stroke in the United States

1 reference

12 December 2020

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor

1 reference

12 December 2020

The Warfarin-Aspirin Symptomatic Intracranial Disease Study

1 reference

12 December 2020

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

1 reference

12 December 2020

Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting

1 reference

12 December 2020

Editorial comment--an approach to the estimation of the risk of TTP during clopidogrel therapy.

1 reference

12 December 2020

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

1 reference

12 December 2020

Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989

1 reference

12 December 2020

Survival and recurrence following stroke. The Framingham study

1 reference

12 December 2020

Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group

1 reference

12 December 2020

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

12 December 2020

Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study

1 reference

12 December 2020

Vascular event rates in patients with atherosclerotic cerebrovascular disease

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

1 reference

12 December 2020

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

1 reference

12 December 2020

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

1 reference

12 December 2020

Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial

1 reference

12 December 2020

Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage

1 reference

12 December 2020

Prevention of stroke with ticlopidine: who benefits most? TASS Baseline and Angiographic Data Subgroup

1 reference

12 December 2020

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

12 December 2020

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

12 December 2020

Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease

1 reference

12 December 2020

European Stroke Prevention Study. ESPS Group

1 reference

12 December 2020

The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks

1 reference

12 December 2020

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura after stenting and ticlopidine

1 reference

12 December 2020

Triflusal posttreatment inhibits glial nuclear factor-kappaB, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain.

1 reference

12 December 2020

Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial

1 reference

12 December 2020

Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascula patients?

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study

1 reference

12 December 2020